|
|
chimeric anti-phosphotidylserine monoclonal antibody An IgG3 monoclonal antibody directed against anionic phospholipids with potential antineoplastic activity. Chimeric anti-phosphotidylserine monoclonal antibody binds to anionic phospholipids in a beta 2-glycoprotein I-dependent manner, inhibiting tumor growth by stimulating antibody-dependent cellular cytotoxicity (ADCC) to tumor vessels. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
US brand name: | | Tarvacin | | |
|
|